| Prevalence of noninfectious uveitis in the United States: a claims-based analysis JE Thorne, E Suhler, M Skup, S Tari, D Macaulay, J Chao, A Ganguli JAMA ophthalmology 134 (11), 1237-1245, 2016 | 231 | 2016 |
| Integrated telehealth and care management program for Medicare beneficiaries with chronic disease linked to savings LC Baker, SJ Johnson, D Macaulay, H Birnbaum Health Affairs 30 (9), 1689-1697, 2011 | 147 | 2011 |
| Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs JE Signorovitch, D Macaulay, M Diener, Y Yan, EQ Wu, JB Gruenberger, ... Diabetes, obesity and metabolism 15 (4), 335-341, 2013 | 143 | 2013 |
| The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States P Martinez‐Martin, D Macaulay, YJ Jalundhwala, F Mu, E Ohashi, ... Movement Disorders 34 (2), 236-245, 2019 | 79 | 2019 |
| Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis WM Reichmann, YF Yu, D Macaulay, EQ Wu, SD Nathan BMC pulmonary medicine 15, 1-13, 2015 | 78 | 2015 |
| Direct and indirect resource use, healthcare costs and work force absence in patients with non‐infectious intermediate, posterior or panuveitis JE Thorne, M Skup, N Tundia, D Macaulay, C Revol, J Chao, A Joshi, ... Acta Ophthalmologica 94 (5), e331-e339, 2016 | 66 | 2016 |
| Effects of care management and telehealth: a longitudinal analysis using medicare data LC Baker, DS Macaulay, RA Sorg, MD Diener, SJ Johnson, HG Birnbaum Journal of the American Geriatrics Society 61 (9), 1560-1567, 2013 | 49 | 2013 |
| Economic burden of patients with inadequate response to targeted immunomodulators for rheumatoid arthritis V Strand, N Tundia, Y Song, D Macaulay, M Fuldeore Journal of managed care & specialty pharmacy 24 (4), 344-352, 2018 | 41 | 2018 |
| Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population SX Wang, AX Ganguli, A Bodhani, JK Medema, WM Reichmann, ... Journal of Medical Economics 20 (12), 1299-1306, 2017 | 37 | 2017 |
| Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States WJ Sandborn, A Sakuraba, A Wang, D Macaulay, W Reichmann, S Wang, ... Current medical research and opinion 32 (7), 1233-1241, 2016 | 36 | 2016 |
| Development and validation of a claims-based prediction model for COPD severity D Macaulay, SX Sun, RA Sorg, SY Yan, G De, EQ Wu, PF Simonelli Respiratory medicine 107 (10), 1568-1577, 2013 | 36 | 2013 |
| Economic burden of non-responders to biologic DMARD treatments in rheumatoid arthritis V Strand, N Tundia, Y Song, D Macaulay, M Fuldeore ARTHRITIS & RHEUMATOLOGY 68, 2016 | 30 | 2016 |
| Impact of a telehealth and care management program on all-cause mortality and healthcare utilization in patients with heart failure DP Kao, JA Lindenfeld, D Macaulay, HG Birnbaum, JL Jarvis, US Desai, ... Telemedicine and e-Health 22 (1), 2-11, 2016 | 29 | 2016 |
| Impact of a telehealth and care management program for patients with chronic obstructive pulmonary disease DH Au, DS Macaulay, JL Jarvis, US Desai, HG Birnbaum Annals of the American Thoracic Society 12 (3), 323-331, 2015 | 27 | 2015 |
| Direct and indirect costs associated with Dupuytren’s contracture D Macaulay, J Ivanova, H Birnbaum, R Sorg, P Skodny Journal of Medical Economics 15 (4), 664-671, 2012 | 27 | 2012 |
| Economic burden of illness among commercially insured patients with systemic sclerosis with interstitial lung disease in the USA: a claims data analysis Z Zhou, Y Fan, D Thomason, W Tang, X Liu, ZY Zhou, D Macaulay, ... Advances in therapy 36, 1100-1113, 2019 | 26 | 2019 |
| Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit … V Sikirica, MH Erder, J Xie, D Macaulay, M Diener, P Hodgkins, EQ Wu Pharmacoeconomics 30, e1-e15, 2012 | 26 | 2012 |
| Economic burden among commercially insured patients with systemic sclerosis in the United States Z Zhou, Y Fan, W Tang, X Liu, D Thomason, ZY Zhou, D Macaulay, ... The Journal of rheumatology 46 (8), 920-927, 2019 | 19 | 2019 |
| Direct costs in patients with celiac disease in the USA: A retrospective claims analysis S Guandalini, N Tundia, R Thakkar, D Macaulay, K Essenmacher, ... Digestive diseases and sciences 61, 2823-2830, 2016 | 18 | 2016 |
| Short-term costs associated with non-medical switching in autoimmune conditions A Gibofsky, M Skup, M Yang, M Mittal, D Macaulay, A Ganguli Clin Exp Rheumatol 37 (1), 97-105, 2019 | 17 | 2019 |
